Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-10-20
2008-12-09
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S301700, C548S302700, C548S303100, C546S152000, C546S168000, C546S268400, C546S273100, C544S106000, C544S139000, C544S242000, C544S335000, C514S231500, C514S256000, C514S311000
Reexamination Certificate
active
07462637
ABSTRACT:
Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide which exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.
REFERENCES:
patent: 6355664 (2002-03-01), Kelly et al.
patent: 6492408 (2002-12-01), Wu et al.
patent: 6689804 (2004-02-01), Wu et al.
patent: 6844360 (2005-01-01), Kelly et al.
patent: 6852748 (2005-02-01), Kelly et al.
patent: WO 98/39303 (1998-09-01), None
patent: WO 01/07440 (2001-02-01), None
Kelly Terence A.
Kim Jin Mi
Lemieux René Marc
Tschantz Matt Aaron
Boehringer Ingelheim Pharmaceuticals Inc.
Datlow Philip I.
Devlin Mary-Ellen M.
Morris Michael P.
Shameem Golam M
LandOfFree
Derivatives of [6,7-dihydro-5 H -imidazo[1,2- -a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of [6,7-dihydro-5 H -imidazo[1,2- -a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of [6,7-dihydro-5 H -imidazo[1,2- -a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4027115